Drug Shortage Report for SULCRATE
| Report ID | 100515 |
| Drug Identification Number | 02100622 |
| Brand name | SULCRATE |
| Common or Proper name | sucralfate |
| Company Name | APTALIS PHARMA CANADA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | SUCRALFATE |
| Strength(s) | 1G |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100 |
| ATC code | A02BX |
| ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2019-12-06 |
| Estimated end date | |
| Actual end date | 2020-01-14 |
| Shortage status | Resolved |
| Updated date | 2020-01-15 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | Company contact information; Telephone number: 800-668-6424 Email address: MR-GENERAL_INQUIRY@allergan.com Website address: allergan.ca Postal address: 500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2020-01-15 | English | Compare |
| v6 | 2020-01-14 | French | Compare |
| v5 | 2020-01-14 | English | Compare |
| v4 | 2020-01-14 | French | Compare |
| v3 | 2020-01-14 | English | Compare |
| v2 | 2019-12-07 | French | Compare |
| v1 | 2019-12-07 | English | Compare |
Showing 1 to 7 of 7